Novartis recalls eye drops in Philippines; Akorn investing $18M in GA plant; Lyka Labs offloads plant;

> Novartis ($NVS) has recalled a batch of eye drops in the Philippines after it learned of good manufacturing practice problems at its ingredient supplier. Article

> Akorn has begun work on an $18 million, 40,000-square-foot expansion to add production capacity at its plant in Decatur, GA. Piece

> India's Lyka Labs has sold its manufacturing facility in Tarapur to an unidentified company for $6.3 million. News

> DSR Labs has invested $2.4 million in an Indian formulation plant in an attempt to win partnerships with pharma companies. Article

And Finally... A World Customs Organization-led operation has seized more than 100 million counterfeit pills at 15 ports in Africa. Item

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.